NCT05255354View on ClinicalTrials.gov

Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

September 1, 2025

Study Completion Date

December 31, 2026

Conditions
Follicular LymphomaDiffuse Large B Cell LymphomaMantle Cell Lymphoma
Interventions
DEVICE

ClonoSEQ

Cancer clonotype sequences are identified in diagnostic 'ID' samples and then sequence frequencies are measured in follow up samples.

Trial Locations (1)

94306

RECRUITING

Stanford Cancer Center, Palo Alto

Sponsors
All Listed Sponsors
collaborator

Stanford University

OTHER

lead

Adaptive Biotechnologies

INDUSTRY